← Eichor
Study identifier: NCT06390696 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Sand Play - the Effect of Biodiversity Exposure on Atopic Dermatitis

Condition: Atopic Dermatitis · Nature, Human · Microbial Colonization  ·  Sponsor: Natural Resources Institute Finland

PhaseNA
Planned participants80
Who can joinAll sexes, 2 Years to 5 Years
Healthy volunteersYes

About this study

The prevalence of atopic dermatitis has increased along with urbanization and biodiversity loss. According to biodiversity hypothesis, the main reason is urban lifestyle and reduced contact to microbial diversity. Previous studies indicate association between atopic dermatitis and exposure to natural microbes in childhood. Sand Play - the Effect of Biodiversity Exposure on Atopic Dermatitis will investigate whether the exposure to microbial diversity in sandbox reduces the symptoms of atopic dermatitis, alters commensal microbiota and modifies immune regulation in children.

This description comes directly from the study's public registry record.

Talk to the study team

Sanna Hurtola  ·  +358295322500  ·  sanna.hurtola@luke.fi

Always discuss trial participation with your own doctor first.

Locations (2)

Natural Resources Institute FinlandHelsinki, Uusimaa, FinlandRecruiting
Tampere UniversityTampere, FinlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06390696